mrr pvt. Ltd.

United States Biosimilars Market Report 2017

Press Release   •   Feb 27, 2017 16:36 IST

p { margin-bottom: 0.25cm; line-height: 120%; }a:link { }

This report studies sales (consumption) of Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Sandoz International

Hospira

Teva Pharmaceutical

Dr. Reddys Laboratories

Biocon

Mylan

Amgen

Celltrion

Roche Diagnostics

Merck KGaA

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Biosimilars Market Report 2017

1 Biosimilars Overview

1.1 Product Overview and Scope of Biosimilars

1.2 Classification of Biosimilars

1.2.1 Type I

1.2.2 Type II

1.3 Application of Biosimilars

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilars (2012-2022)

1.4.1 United States Biosimilars Sales and Growth Rate (2012-2022)

1.4.2 United States Biosimilars Revenue and Growth Rate (2012-2022)

Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/994222